Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeming Wang

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 17, 2021
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19Lili Ren, Yeming Wang, Jiaxin Zhong, et al.
Lancet (London, England)|January 28, 2020
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaChaolin Huang, Yeming Wang, Xingwang Li, et al.
The New England Journal of Medicine|January 17, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19Bin Cao, Yeming Wang, Hongzhou Lu, et al.
Lancet (London, England)|June 15, 2023
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
Lancet (London, England)|January 11, 2021
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
Ebiomedicine|November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenzaYeming Wang, Wu Zhong, Alex Salam, et al.
The Lancet. Infectious Diseases|April 25, 2024
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in ChinaWenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
Lancet (London, England)|May 20, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialYeming Wang, Dingyu Zhang, Guanhua Du, et al.
The Journal of Infectious Diseases|April 13, 2018
Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus InfectionYeming Wang, Qiang Guo, Zheng Yan, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Respiratory and Critical Care Medicine|September 17, 2021
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19Lili Ren, Yeming Wang, Jiaxin Zhong, et al.
Lancet (London, England)|January 28, 2020
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaChaolin Huang, Yeming Wang, Xingwang Li, et al.
The New England Journal of Medicine|January 17, 2024
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19Bin Cao, Yeming Wang, Hongzhou Lu, et al.
Lancet (London, England)|June 15, 2023
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
Lancet (London, England)|January 11, 2021
6-month consequences of COVID-19 in patients discharged from hospital: a cohort studyChaolin Huang, Lixue Huang, Yeming Wang, et al.
Ebiomedicine|November 24, 2020
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenzaYeming Wang, Wu Zhong, Alex Salam, et al.
The Lancet. Infectious Diseases|April 25, 2024
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in ChinaWenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet. Respiratory Medicine|February 24, 2023
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trialsAlain Amstutz, Benjamin Speich, France Mentré, et al.
Lancet (London, England)|May 20, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialYeming Wang, Dingyu Zhang, Guanhua Du, et al.
The Journal of Infectious Diseases|April 13, 2018
Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus InfectionYeming Wang, Qiang Guo, Zheng Yan, et al.
Pageof 16